Senior Oncology Sales Specialist at Illumina

Bengaluru, Karnataka, India

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, Healthcare, OncologyIndustries

Requirements

Recognized deep expertise in oncology segment and ability to independently work on highly complex problems requiring analysis of multiple variables
Demonstrated proactiveness in initiating and accomplishing tasks to drive oncology business
Demonstrated ability to work effectively within a team
Excellent time management skills – able to prioritize workload accordingly
Demonstrated communication (verbal and written), presentation, and training skills
Familiarity with the competitive landscape

Responsibilities

Serve as the subject matter expert for oncology applications and act as the voice of the customer to regional management, global product teams, marketing, and market development
Demonstrate comprehensive knowledge of the market landscape, including current and emerging trends, competitive dynamics, industry practices, and strategic positioning
Advise customers on technical aspects such as end-to-end workflows, study design, product selection and positioning, and competitor differentiation; apply innovative solutions to address technical and strategic barriers
Collaborate with district sales teams to deliver deep domain expertise, including the discussion of relevant publications and scientific or clinical literature with key customers
Maintain in-depth knowledge of Illumina’s product portfolio and articulate the value proposition to diverse customer segments
Deliver compelling presentations to drive market engagement and generate interest in Illumina technologies
Be recognized by the scientific and clinical community as a thought leader and sought-after contributor for discussions and conference programs
Represent the organization at industry trade shows and conferences to build visibility, network, and stay informed on market trends
Collaborate with district sales and marketing teams to develop and execute strategic plans aimed at winning new business, expanding market share, and enhancing existing programs, as evidenced by a qualified pipeline of opportunities
Provide strategic recommendations to sales management on market approaches for introducing new assays and technologies or supporting customers in developing new test menu within the target customer base
Maintain a strong field presence by regularly visiting customers to strengthen relationships, implement effective selling strategies and tactics, and drive key sales opportunities for Illumina’s products
Identify and engage key opinion leaders (KOLs) and influential customers within the clinical segment to uncover new sales opportunities and facilitate the adoption of Illumina technologies in new customer groups
Partner with sales and marketing teams to research and identify new clinical market opportunities
Collaborate closely with internal team to assess regional markets and determine the feasibility of introducing new clinical applications
Support additional business development initiatives as time and priorities allow

Skills

Oncology

Genomics

Sales

Market Analysis

Competitive Intelligence

Workflows

Study Design

Product Positioning

Scientific Literature

Presentations

Illumina

Supports genomics startups through funding and resources

About Illumina

Illumina focuses on fostering innovation in the genomics industry by supporting startups through its Illumina Accelerator program. This program helps entrepreneurs create, launch, and grow genomics-focused companies by providing funding and resources. The accelerator operates in two main locations: the San Francisco Bay Area and Cambridge, UK. Illumina Accelerator has successfully invested in 68 genomics startups, which have collectively raised over $1 billion in venture capital. What sets Illumina apart from its competitors is its strong partnership with leading venture capital investors and its dedicated focus on the genomics sector. The goal of Illumina is to build a thriving ecosystem for genomics innovation, enabling new companies to emerge and advance the field.

San Diego, CaliforniaHeadquarters

1998Year Founded

$27.2MTotal Funding

IPOCompany Stage

Venture Capital, BiotechnologyIndustries

5,001-10,000Employees

Risks

Over-reliance on NVIDIA's AI technology may limit flexibility in AI solution adoption.

Standardizing proteomics data across platforms could challenge Illumina's data reliability.

Single-flow-cell NovaSeq X System might cannibalize sales of higher-end models.

Differentiation

Illumina leads in genomic sequencing with advanced AI integration and multiomic data analysis.

The company offers innovative array-based solutions for DNA, RNA, and protein analysis.

Illumina's global expansion includes a new Global Capability Center in Bengaluru.

Upsides

Collaboration with NVIDIA enhances drug discovery and clinical development through AI integration.

Pilot proteomics program with UK Biobank aims to generate crucial reference datasets.

Single-cell sequencing kits make high-throughput sequencing accessible to smaller labs.

Land your dream remote job 3x faster with AI

Try Jobo Free